NEW YORK (360Dx) – VANC Pharmaceutical today announced a shared purchase agreement to acquire all outstanding common shares of HealthTab, a point-of-care platform for Canadian pharmacists for cholesterol, triglyceride, and other testing and monitoring.

Under the terms of the deal, VANC will pay C$200,000 (US$157,471) in cash to HealthTab's vendors, including C$100,000 at closing. The balance will be subsequently paid in six equal installments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.